Vascular Solutions Inc
VASC
VASC was delisted on the 17th of February, 2017.
1 hedge funds and large institutions have $61K invested in Vascular Solutions Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 157 closing their positions.
99% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 157
99% less funds holding
Funds holding: 163 → 1 (-162)
100% less capital invested
Capital invested by funds: $783M → $61K (-$783M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPF
FNY Partners Fund
New York
|
+$61.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$47.9M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$43.7M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$41.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$37.6M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$32.1M |
VASC Hedge Fund Activity: Q1 2017 in Review
1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Vascular Solutions Inc (VASC) for Q1 2017, worth a combined $61K — down 100% from $783M a quarter earlier.
Sellers outnumbered buyers: 157 funds closed out of VASC and 1 opened new positions — a net loss of 156 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was FNY Partners Fund, opening a new position worth an estimated $61.5K. The largest seller was Vanguard Group, exiting entirely with an estimated $47.9M sold.
- 1 institutional investor held Vascular Solutions Inc (VASC) as of Q1 2017, down from 163 in Q4 2016.
- Funds reported $61K of Vascular Solutions Inc stock for Q1 2017, down 100% quarter-over-quarter.
- 1 fund opened new Vascular Solutions Inc positions in Q1 2017 and 157 closed out, a net change of -156 holders.
- The largest Vascular Solutions Inc buyer in Q1 2017 was FNY Partners Fund, an estimated $61.5K added.
- The largest Vascular Solutions Inc seller in Q1 2017 was Vanguard Group, an estimated $47.9M sold.
Based on aggregated 13F filings for Q1 2017.